Mead Johnson Nutrition CO (NYSE:MJN)‘s stock had its “outperform” rating reaffirmed by research analysts at BMO Capital Markets in a research report issued on Friday. They presently have a $97.00 target price on the stock. BMO Capital Markets’ price objective would suggest a potential upside of 22.40% from the company’s current price.

Other research analysts have also issued reports about the company. Susquehanna reiterated a “hold” rating and set a $95.00 target price on shares of Mead Johnson Nutrition CO in a report on Monday, August 29th. Credit Suisse Group AG set a $100.00 target price on Mead Johnson Nutrition CO and gave the stock a “buy” rating in a report on Monday, September 12th. Citigroup Inc. reduced their target price on Mead Johnson Nutrition CO from $106.00 to $103.00 and set a “buy” rating on the stock in a report on Thursday, September 8th. Societe Generale lowered Mead Johnson Nutrition CO from a “buy” rating to a “hold” rating and reduced their target price for the stock from $100.00 to $95.00 in a report on Friday, July 29th. Finally, Zacks Investment Research lowered Mead Johnson Nutrition CO from a “buy” rating to a “hold” rating in a report on Monday, June 13th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $95.75.

Mead Johnson Nutrition CO (NYSE:MJN) traded down 0.82% on Friday, reaching $78.60. The company had a trading volume of 458,227 shares. The stock has a market capitalization of $14.51 billion, a price-to-earnings ratio of 29.57 and a beta of 1.17. Mead Johnson Nutrition CO has a 12 month low of $65.53 and a 12 month high of $94.40. The firm has a 50 day moving average price of $83.30 and a 200-day moving average price of $84.69.

Mead Johnson Nutrition CO (NYSE:MJN) last posted its quarterly earnings results on Thursday, July 28th. The company reported $0.88 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.10. Mead Johnson Nutrition CO had a negative return on equity of 194.30% and a net margin of 13.28%. The business had revenue of $941.50 million for the quarter, compared to analyst estimates of $967.25 million. During the same period last year, the company earned $0.76 EPS. The firm’s revenue was down 8.8% on a year-over-year basis. Analysts forecast that Mead Johnson Nutrition CO will post $3.49 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 3rd. Investors of record on Monday, September 19th will be given a $0.4125 dividend. This represents a $1.65 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date of this dividend is Thursday, September 15th. Mead Johnson Nutrition CO’s dividend payout ratio is currently 62.03%.

In related news, SVP Graciela Monteagudo sold 45,873 shares of Mead Johnson Nutrition CO stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $87.64, for a total value of $4,020,309.72. Following the sale, the senior vice president now owns 13,800 shares of the company’s stock, valued at $1,209,432. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Kimberly A. Casiano sold 710 shares of Mead Johnson Nutrition CO stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $89.75, for a total value of $63,722.50. Following the completion of the sale, the director now directly owns 7,110 shares in the company, valued at approximately $638,122.50. The disclosure for this sale can be found here. 0.50% of the stock is owned by corporate insiders.

Several hedge funds have recently added to or reduced their stakes in the stock. Williams Jones & Associates LLC bought a new stake in Mead Johnson Nutrition CO during the second quarter worth about $984,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in shares of Mead Johnson Nutrition CO during the second quarter worth $684,000. Kentucky Retirement Systems acquired a new position in shares of Mead Johnson Nutrition CO during the second quarter worth $1,441,000. Mason Street Advisors LLC acquired a new position in shares of Mead Johnson Nutrition CO during the second quarter worth $2,282,000. Finally, Northwestern Mutual Wealth Management Co. increased its position in shares of Mead Johnson Nutrition CO by 11.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,287 shares of the company’s stock worth $118,000 after buying an additional 131 shares during the period. 96.93% of the stock is currently owned by institutional investors and hedge funds.

About Mead Johnson Nutrition CO

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

5 Day Chart for NYSE:MJN

Receive News & Ratings for Mead Johnson Nutrition CO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related companies with MarketBeat.com's FREE daily email newsletter.